Aurinia Pharmaceuticals AUPH Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's total cost of revenue?
- Aurinia Pharmaceuticals (AUPH) reported total cost of revenue of $6.51M in Q1 2026.
- How has Aurinia Pharmaceuticals's total cost of revenue changed year-over-year?
- Aurinia Pharmaceuticals's total cost of revenue decreased by 24.1% year-over-year, from $8.57M to $6.51M.
- What is the long-term trend for Aurinia Pharmaceuticals's total cost of revenue?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's total cost of revenue has grown at a 133.9% compound annual growth rate (CAGR), from $1.09M to $32.67M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.